Chemoinformaics analysis of Chrysin 7-glucuronide
| Molecular Weight | 430.365 | nRot | 4 |
| Heavy Atom Molecular Weight | 412.221 | nRig | 25 |
| Exact Molecular Weight | 430.09 | nRing | 4 |
| Solubility: LogS | -3.958 | nHRing | 2 |
| Solubility: LogP | 1.896 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 55.0923 |
| nHD | 5 | BPOL | 25.0017 |
| QED | 0.392 |
| Synth | 3.767 |
| Natural Product Likeliness | 1.621 |
| NR-PPAR-gamma | 0.937 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.398 |
| HIA | 0.36 |
| CACO-2 | -6.308 |
| MDCK | 0.000023 |
| BBB | 0.053 |
| PPB | 0.892235 |
| VDSS | 0.568 |
| FU | 0.0700576 |
| CYP1A2-inh | 0.086 |
| CYP1A2-sub | 0.045 |
| CYP2c19-inh | 0.049 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.486 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.144 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.009 |
| CL | 0.865 |
| T12 | 0.684 |
| hERG | 0.062 |
| Ames | 0.032 |
| ROA | 0.028 |
| SkinSen | 0.066 |
| Carcinogencity | 0.424 |
| EI | 0.024 |
| Respiratory | 0.063 |
| NR-Aromatase | 0.186 |
| Antiviral | Yes |
| Prediction | 0.854654 |